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99 mmol/L]. 11 (31.4%) subjects were insufficient and 11
(31.4%) were severely deficient.
Conclusions Prevalence of VitD deficiency was 62%. Testing
and supplementation is cheap: test costs 70 p, supplementation
costs £8 – £12. A simple test, treatment alleviates symptoms
and may reduce fractures in fall prone patients.
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Introduction Successful Trainee Clinical Research Networks
have been established since 2007 and are primarily run by
Surgical and Anaesthetic Trainees. In the southwest peninsula
we have set up the first UK Neurology Trainee Audit and
Research Collaborative to deliver clinical studies. Ensuring all
trainees have appropriate training is a key requirement; we
aimed to ascertain the training needs of our network
members.
Method A survey was sent to all 9 neurology trainees in the
Peninsula Deanery. It comprised 5 questions to establish
trainee clinical research training and experience.
Results Response rate was 100%. Training level varied from
ST3–5; 22% had previously completed higher degrees. 40%
of trainees had not been involved in clinical research. One
trainee had not had formal good clinical practice (GCP) train-
ing and none had formal Informed Consent training. Of those
who had been involved in research, there had been limited
involvement in project design, ethics approval processes, data
analysis, manuscript preparation or findings presentation.
Conclusion We identified a training need in our Trainee Audit
and Research Network. In order to address this, we have
organised formal GCP and Informed Consent training; to
broaden the research experience of network members, we are
planning our first collaborative research project.
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Background Survivors of bacterial meningitis are known to
suffer neuropsychological deficits after their acute illness. Pre-
vious studies have suggested that viral meningitis may also
cause cognitive problems.
Primary and Objective We aimed to determine what the neuro-
psychological problems encountered by adults with viral men-
ingitis were compared to healthy patients without meningitis
and how long their problems lasted.
Methods Patients with viral meningitis and healthy controls
completed the ‘Aldenkamp and Baker Neuropsychological
Assessment Schedule (ABNAS)’, a 24 item self-administered
questionnaire. Patients completed the ABNAS at 4 time points
– 6, 12, 24 and 48 weeks post acute illness. Higher ABNAS
scores correspond to greater levels of neuropsychological dys-
function, with a worst score possible of 72.
Results Healthy controls (n=224) had a mean total ABNAS
score of 7. Comparatively, the patients with viral meningitis
had significantly worse scores at all 4 time points. At 6 weeks
scoring 22 (p<0.001) (n=73), at 12 Weeks 19.5 (p<0.001)
(n=102), at 24 weeks 13.5 (p 0.002) (n=86) and at 48 weeks
16.5 (p<0.001) (n=76).
Conclusions Patients with viral meningitis have significantly
worse neuropsychological deficits compared to healthy con-
trols. The deficits showed some improvement initially but
failed to improve significantly beyond 24 weeks.
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Aims To assess neurological admissions to the critical care unit
in our centre according to published prioritisation criteria and
evaluate predictors of outcome.
Methods We reviewed 39 patient records between November
2012-April 2015, and ranked from 1 to 4 according to priori-
tisation criteria. We evaluated predictors of outcome, including
length of stay, using regression modelling.
Results 18 females and 21 males were assessed with a mean
age of 41 years (range 23–83). Twelve patients had strokes, 6
status epilepticus, 16 neuromuscular disorders, 1 post-arrest
hypoxia-ischaemia, 3 metabolic problems and 1 meningitis. Six
patients had serious co-morbidities. Mean time from ward to
critical care was 5 days (range 0–39), time on critical care
was 10 days (0–45), and time from critical care to home 23
days (2–84). Sixty-six percent received non-invasive ventilation,
51% intubation and ventilation, 27% tracheostomy and 8%
inotropes. 23 patients were classed priority 1, 9 priority 2
and 7 priority 3. Seventy-four percent survived to discharge
to the ward and of these 93% went home. Of survivors, 62%
had a Rankin score 1–2. All the priority 3 patients died.
There was no association between length of stay and
outcome.
Conclusions Neurological patients in critical care generally
have good outcomes, even with prolonged stays. Meeting pri-
ority 3 criteria was associated with poor prognosis.
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Motor Neurone Disease (MND) is more common in the HIV
positive population, for reasons that are unclear. MND in
these patients is indistinguishable from sporadic MND. Recent
evidence proposes a role for endogenous retroviruses in
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